High Purity N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl Ester for Pharmaceutical Synthesis

Source critical pharmaceutical intermediates with confidence. Discover our high-purity N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl Ester, a key building block for advanced antiviral drug development. We are a trusted manufacturer and supplier in China.

Get a Quote & Sample

Advantages of Sourcing from Us

Guaranteed Quality & Purity

We ensure rigorous quality control throughout the manufacturing process, providing you with a pharmaceutical intermediate that meets the highest standards for purity and efficacy, vital for your research and production needs.

Expertise in Pharmaceutical Intermediates

Leverage our deep expertise in fine chemical synthesis. We are a trusted supplier of N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl Ester, understanding the critical requirements of the pharmaceutical industry.

Global Supply Chain and Support

We provide efficient logistics and responsive customer service, ensuring timely delivery of your pharmaceutical intermediate needs globally. Contact us for a quote and to discuss your bulk purchase requirements.

Key Applications

Antiviral Prodrug Synthesis

This intermediate is a fundamental component in the synthesis of phosphoramidate prodrugs, including those targeting Hepatitis C (HCV), significantly advancing antiviral therapy development.

Pharmaceutical Research & Development

Researchers rely on high-purity intermediates like this alanine derivative for exploring new drug candidates and optimizing synthesis routes for complex APIs.

API Manufacturing

For active pharmaceutical ingredient manufacturers, securing a consistent and high-quality supply of this compound is essential for reliable and efficient production processes.

Custom Synthesis Projects

We support custom synthesis projects, offering this intermediate as a starting material or key component for specialized chemical development by contract research organizations (CROs).